Education
About Us
Working with TipRanks
Follow Us
COMPASS Pathways (DE:5Y6)
FRANKFURT:5Y6
Earnings Data
Report Date
Feb 26, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.34Last Year’s EPS
-0.55Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with significant progress in clinical trials, regulatory interactions, and launch preparations. While there was a decrease in cash reserves, the company maintains a strong cash position with a runway into 2027.Company Guidance
Acceleration of Launch Plans
COMPASS Pathways announced a 9- to 12-month acceleration of their launch plans for COMP360, highlighting excellent progress.
Successful Phase III Trial Results
The first Phase III trial, COMP005, demonstrated a highly statistically significant result for the primary endpoint, marking an important derisking event for the company.
Completion of Enrollment for Second Phase III Trial
COMPASS completed enrollment for the COMP006 trial, which will inform dosing for labeling and clarify timing for data disclosures.
Positive Interaction with FDA
The company had a positive and collaborative interaction with the FDA, supporting the acceleration of the planned NDA filing for COMP360 in TRD, including the potential for a rolling submission.
Strong Cash Position
As of the end of September, COMPASS had $186 million in cash and cash equivalents, with a cash runway into 2027.
Launch Readiness Advancements
Significant progress in commercial preparations, including strategic collaborations and understanding of the commercial landscape, was highlighted.
DE:5Y6 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:5Y6 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 04, 2025 | €5.45 | €5.35 | -1.83% |
Jul 31, 2025 | €3.66 | €3.42 | -6.56% |
May 08, 2025 | €3.10 | €3.30 | +6.45% |
Feb 27, 2025 | €3.36 | €3.70 | +10.12% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does COMPASS Pathways (DE:5Y6) report earnings?
COMPASS Pathways (DE:5Y6) is schdueled to report earning on Feb 26, 2026, Before Open (Confirmed).
What is COMPASS Pathways (DE:5Y6) earnings time?
COMPASS Pathways (DE:5Y6) earnings time is at Feb 26, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of COMPASS Pathways stock?
The P/E ratio of COMPASS Pathways is N/A.
What is DE:5Y6 EPS forecast?
DE:5Y6 EPS forecast for the fiscal quarter 2025 (Q4) is -0.34.